Forest Inks Alzheimer's Drug Deal - Analyst Blog | Medical Informer

Home

Home » Medicine & Supplements » Lexapro » Forest Inks Alzheimer's Drug Deal – Analyst Blog

Forest Inks Alzheimer's Drug Deal – Analyst Blog

Posted on 28 November 2012. Tags: Alzheimer&#39s, Analyst, Blog, Deal, Drug, Forest, Inks

Forest Inks Alzheimer's Drug Deal – Analyst Blog
We currently have a Neutral recommendation on Forest Labs. The stock carries a Zacks #4 Rank (short-term Sell rating). Forest Labs has been under a lot of pressure following the entry of generic versions of its depression drug, Lexapro, earlier this year.

Full News here – Read more on NASDAQ

Leave a Reply Cancel reply

Latest
Popular
Comments
Tags
Subscribe

Child Unharmed After Two Story Fall Out of a Window June 18, 2013
Offices in Monroe Hall moving due to construction June 18, 2013
To Your Good Health: How do arthritis types differ? June 18, 2013
Diabetes heilen – einfach und natürlich – Medical Informer Video June 18, 2013
Weight Loss, Sex Supplements Tainted Says FDA June 18, 2013

lasik November 2, 2011
CT scan (3/13) – Medical Informer Video November 12, 2011
Cosmetic Surgery Documentary – Ethnic Nose Job – Plastic Surgeon Beverly Hills – Medical Informer Video November 23, 2011
Aspirin Toner – Medical Informer Video November 29, 2011
Animation about diabetes and the body. – Medical Informer Video December 5, 2011